LON:0A87 Revenue

Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending September 30, 2025, a decrease of -5.38%. This brings the company's revenue in the last twelve months to 4.42T, down -2.84% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.

Revenue (ttm)

4,417.00B JPY

Revenue Growth

-2.84%

P/S Ratio

1.52

Revenue / Employee

93.08M JPY

Employees

47,455

Market Cap

33.64B GBP

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4,581.55B	317.79B	7.45%
Mar 31, 2024	4,263.76B	236.28B	5.87%
Mar 31, 2023	4,027.48B	458.47B	12.85%
Mar 31, 2022	3,569.01B	371.19B	11.61%
Mar 31, 2021	3,197.81B	-93.38B	-2.84%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.24B
HSBC Holdings	43.13B
Shell	200.18B
Unilever	51.24B
Rio Tinto Group	39.22B
British American Tobacco p.l.c.	25.60B
Rolls-Royce Holdings	19.54B
GSK plc	32.17B

Revenue Rankings